ArticleJournal of perinatology : official journal of the California Perinatal Association2026
Associations between maternal opioid use disorder treatment and pregnancy outcomes.
Article in Journal of perinatology : official journal of the California Perinatal Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThis study examines associations between opioid use disorder (OUD) treatment and pregnancy outcomes among Medicaid enrollees. STUDY
designUsing 2021 Medicaid claims, we identified 29,193 women with OUD and a pregnancy-related outcome receiving (1) Medication Only, (2) Behavioral Therapy Only, (3) Medication and Behavioral Therapy, or (4) No Treatment. Multivariable logistic regression estimated adjusted odds ratios (ORs) for outcomes.
resultsAmong pregnant women with OUD, over half (52.5%) received no treatment; 27.9% received medication and therapy, 12.5% received medication only, and 7.0% received therapy only. Any form of treatment was linked to reduced risk of fetal death. Medication, alone or with therapy, was associated with lower risk of preterm labor, and medication alone was linked to reduced risk of abruptio placentae.
conclusionReceiving treatment for OUD is significantly associated with better pregnancy outcomes. Expanding access to medication for OUD and integrating therapy are crucial for improving maternal health.
Indexed as
Identifiers
41219511What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.